JPMORGAN CHASE & CO - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 226 filers reported holding EDITAS MEDICINE INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$8,270,269
-10.6%
1,060,291
-5.7%
0.00%0.0%
Q2 2023$9,254,676
+12.7%
1,124,505
-0.7%
0.00%0.0%
Q1 2023$8,214,000
+78210.6%
1,132,951
-4.2%
0.00%0.0%
Q4 2022$10,489
-99.9%
1,182,654
+1.7%
0.00%
-50.0%
Q3 2022$14,239,000
+0.2%
1,163,326
-3.1%
0.00%0.0%
Q2 2022$14,204,000
-40.6%
1,200,601
-4.5%
0.00%
-33.3%
Q1 2022$23,900,000
-38.5%
1,256,561
-14.2%
0.00%
-25.0%
Q4 2021$38,871,000
-16.1%
1,464,063
+29.8%
0.00%
-33.3%
Q3 2021$46,329,000
-25.8%
1,127,758
+2.3%
0.01%
-14.3%
Q2 2021$62,443,000
+54.0%
1,102,447
+14.2%
0.01%
+40.0%
Q1 2021$40,550,000
-1.4%
965,469
+64.6%
0.01%
-16.7%
Q4 2020$41,132,000
+206.7%
586,683
+27.0%
0.01%
+200.0%
Q3 2020$13,411,000
+25.1%
461,785
+27.4%
0.00%0.0%
Q2 2020$10,721,000
+107.8%
362,429
+39.3%
0.00%
+100.0%
Q1 2020$5,159,000
+59.3%
260,139
+137.8%
0.00%0.0%
Q4 2019$3,239,000
+754.6%
109,375
+556.1%
0.00%
Q3 2019$379,000
+18.8%
16,670
+22.3%
0.00%
Q2 2019$319,000
+16.0%
13,632
+21.4%
0.00%
Q1 2019$275,000
-71.6%
11,230
-73.6%
0.00%
Q4 2018$967,000
-41.3%
42,477
-17.9%
0.00%
Q3 2018$1,646,000
-9.3%
51,742
+2.2%
0.00%
Q2 2018$1,814,000
+6.8%
50,629
-1.1%
0.00%
Q1 2018$1,698,000
+619.5%
51,200
+566.8%
0.00%
Q4 2017$236,000
+3833.3%
7,679
+2971.6%
0.00%
Q3 2017$6,000
+50.0%
2500.0%0.00%
Q2 2017$4,000
-33.3%
2500.0%0.00%
Q1 2017$6,000
-75.0%
250
-86.2%
0.00%
Q3 2016$24,000
-99.0%
1,812
-97.5%
0.00%
-100.0%
Q1 2016$2,504,00072,5000.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q1 2023
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 54,615$4,897,0002.55%
Capital Impact Advisors, LLC 130,000$9,114,0002.24%
ARK Investment Management 10,125,564$709,903,0001.89%
Nikko Asset Management Americas, Inc. 4,388,143$307,653,0001.75%
Spectrum Planning & Advisory Services Inc. 17,522$1,228,0001.32%
DDD Partners, LLC 79,527$5,576,0001.10%
Brevan Howard Capital Management LP 76,420$5,358,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 538,721$37,770,0000.75%
DC Investments Management, LLC 3,627$254,0000.63%
Haafor (Singapore) Pte. Ltd. 4,761$334,0000.62%
View complete list of EDITAS MEDICINE INC shareholders